Philippine, Israel, and Brazil are the first three countries that say they are ready to carry out further trials, produce and distribute the Russian-made Sputnik V vaccine.
Vaccine registration without passing the standard test procedure has sparked controversy both within Russia and on the global scene.
The President of the Philippines, Rodrigo Duterte, was the first to demonstrate that he was ready to test and use the Russian-made vaccine, named Sputnik V, for citizens in his country.
Duterte even boasted that he would be the first person to be publicly vaccinated.
But Eric Domingo, director-general of the Philippines Food and Drug Administration, stressed in a television interview that all coronavirus vaccines must pass strict regulatory checks.
Duterte has launched a phase three clinical trial of the Sputnik V vaccine in the Philippines which will start in October.
Israel has also said it will test a Russian-made Covid-19 vaccine.
“If it is proven that it is a serious product, we will try to negotiate, and will buy the vaccine,” said a statement from the Israeli health ministry.
A technology institute in Brazil, in the state of Paraná, predicts that it will start producing the controversial Russian-made coronavirus vaccine in the second half of 2021.
This statement was released after the state of Paraná signed an understanding with Moscow.
Paraná Technology Institute or Tecpar signed a cooperation agreement with the Russian Direct Investment Fund (RDIF).
The cooperation is a target to manage the production of the Sputnik V vaccine and its distribution in Brazil and other countries in Latin America.
Director of Tecpar, Jorge Callado said in a press conference that his party was still waiting for Russia to send the results of phase 1 and phase 2 vaccine trials.
And based on information from Russia, they are still conducting phase 3 clinical trials.
“Paraná is ready to participate in phase 3 clinical trial if permitted by the Brazilian regulatory agency Anvisa,” he concluded.
Whereas previously health experts and former senior officials in drug and vaccine regulation had already expressed their concerns.
They are concerned about the safety of Sputnik V because it does not pass the standard testing process required for vaccination.
